M. Shimaoka et al., KETAMINE INHIBITS NITRIC-OXIDE PRODUCTION IN MOUSE-ACTIVATED MACROPHAGE-LIKE CELLS, British Journal of Anaesthesia, 77(2), 1996, pp. 238-242
We have investigated the effects of ketamine on nitric oxide produced
by activated macrophages using a murine macrophage-like cell line, J77
4. Cells were incubated for 18 h under stimulation with lipopolysaccha
ride and interferon-gamma or lipoteichoic acid and interferon-gamma, w
ith various concentrations of ketamine (6-600 mu mol litre(-1)). Nitri
c oxide production was assessed by measuring nitrite, a stable by-prod
uct of nitric oxide breakdown, in the medium. Other N-methyl-D-asparta
te receptor antagonists, MK-801 (150 mu mol litre(-1)) and dextrometho
rphan (150 mu mol litre(-1)) were also tested. In addition, we studied
the effects of ketamine on production of tumour necrosis factor-alpha
by activated macrophages. Ketamine inhibited nitrite production dose-
dependently with both lipopolysaccharide- and lipoteichoic acid-activa
ted macrophages by up to approximately 65% at the highest ketamine con
centration (600 mu mol litre(-1)). Neither MK-801 nor dextromethorphan
had an inhibitory effect. Ketamine also suppressed production of tumo
ur necrosis factor-alpha. The data show that ketamine inhibited nitric
oxide production by activated macrophages probably, in part, via inhi
bition of production of tumour necrosis factor-alpha, an autocrine sti
mulatory factor for nitric oxide production, but not via the NMDA rece
ptor pathway, which is involved in neuronal nitric oxide production.